RE: 6103 works in human21 Apr 2026 08:58
Its phase 1a they have tweaked because of additional data.
Broader chance of success and seeing early efficacy.
As far as we know they have only dosed 1 patient, we don't know what indication.
Pretty sure they wouldn't be in a panic from that and if the release mechanism wasn't working as expected that patient would be suffering horrendous side effects and the trial halted.